James Schaub

Insider Reports History

Location
Bridgewater, NJ
Signature
/s/ Christopher Klein, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Schaub:

Company Role Class Num Shares Value Price $ Report Date Ownership
RVL Pharmaceuticals plc EVP and COO Ordinary Shares 524,835 $16,375 $0.0312 18 May 2023 Direct

Insider Reports Filed by James Schaub

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465923063324-schaub-james-2023-05-18 RVL Pharmaceuticals plc 18 May 2023 1 -$4,852 4 EVP and COO 22 May 2023, 21:21
/report/000110465923007068-schaub-james-2023-01-24 RVL Pharmaceuticals plc 24 Jan 2023 1 -$12,106 4 EVP and COO 26 Jan 2023, 16:15
/report/000110465922088038-schaub-james-2022-08-08 RVL Pharmaceuticals plc 08 Aug 2022 1 +$232,500 4 EVP and COO 09 Aug 2022, 17:23
/report/000110465922063391-schaub-james-2022-05-18 RVL Pharmaceuticals plc 18 May 2022 1 -$8,782 4 EVP and COO 20 May 2022, 16:25
/report/000110465922007838-schaub-james-2022-01-24 RVL Pharmaceuticals plc 24 Jan 2022 1 -$10,856 4 EVP and COO 26 Jan 2022, 15:30
/report/000110465921151769-schaub-james-2021-12-16 Osmotica Pharmaceuticals plc 16 Dec 2021 1 +$100,366 4 EVP and COO 20 Dec 2021, 16:03
/report/000110465921135640-schaub-james-2021-11-04 Osmotica Pharmaceuticals plc 04 Nov 2021 1 $0 4 EVP and COO 08 Nov 2021, 15:07
/report/000110465921069884-schaub-james-2021-05-18 Osmotica Pharmaceuticals plc 18 May 2021 1 -$20,658 4 EVP and COO 20 May 2021, 16:07